PVLA
Palvella Therapeutics
PVLA
PVLA
24 hedge funds and large institutions have $10.1M invested in Palvella Therapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.4M | |
| 2 | +$699K | |
| 3 | +$373K | |
| 4 |
Renaissance Technologies
New York
|
+$343K |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$267K |
Top Sellers
| 1 | -$127K | |
| 2 | -$101K | |
| 3 | -$22.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.28K |
| 5 |
HVIA
Hudson Valley Investment Advisors
Goshen,
New York
|
-$2.4K |